Juan Kattan, M.D.

Juan N Kattan, M.D. - Research & Publications

(352) 265-3589

Publications

  • Kattan JN, Villegas MV, Quinn JP. "New Developments in Carbapenems" Clin Microbiol Infect 2008 Dec;14(12):1102-11. PMID: 19076841.
  • Villegas MV, Kattan JN, Quinteros MG, Casellas JM. "Prevalence of Extended Spectrum Beta-lactamases (ESBLs) in South America" Clin Microbiol Infect. 2008 Jan;14 Suppl 1:154-8. Erratum in: Clin Microbiol Infect. 2008. May;14 Suppl 5:21-4.. PMID: 18154539
  • Villegas MV, Kattan JN, Correa A, Lolans K, Guzman AM, Woodford N, Livermore D, Quinn JP and the Colombian Nosocomial Bacterial Resistance Study Group. "Acinetobacter Baumannii con Carbapenemasa OXA-23 en Colombia" Rev Chil Infect 2007; 24 (6): 500-503.
  • Villegas MV, Kattan JN, Correa A, Lolans K, Guzman AM, Woodford N, Livermore D, Quinn JP and the Colombian Nosocomial Bacterial Resistance Study Group. "Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals" Antimicrob Agents Chemother 2007; 51(6):2001-4. PMID: 17403994
  • Villegas MV, Lolans K, Correa A, Kattan JN, Lopez J and Quinn JP. "First Identification of Pseudomonas Aeruginosa Isolates Producing a KPC-type Carbapenem-hydrolyzing Beta-lactamase" Antimicrob Agents Chemother 2007; 51(4):1553-5. PMID: 17261621.
  • Suarez CJ, Kattan JN, Guzman AM, Villegas MV. "Mecanismos de Resistencia a Carbapenems en P. Aeruginosa, Acinetobacter y
  • Enterobacteriaceae y Estrategias para su Prevenci and oacute;n y Control" Infectio 2006; 10(2):85-93.